Keratinocyte antimicrobial peptide expression machinery

The keratinocyte antimicrobial peptide (AMP) expression machinery is a complex biological system responsible for the production of endogenous antibiotics that form the primary chemical barrier of the skin. This machinery is activated by various stimuli, including physical injury, pathogenic invasion, and metabolic signals like Vitamin D, which act through receptors such as Toll-like receptors (TLRs) and the Vitamin D receptor (VDR) [1][2]. Upon activation, these receptors initiate signaling pathways—most notably the JAK-STAT and NF-kB pathways—that drive the synthesis of key peptides like cathelicidin (LL-37) and beta-defensins [3][4]. These peptides not only kill microbes directly but also act as alarmins to recruit and activate adaptive immune cells [5]. In clinical practice, this machinery is a focal point for treating inflammatory skin diseases; for example, Vitamin D analogs are used to modulate AMP expression in psoriasis, where the system is overactive, while research continues into boosting these defenses in atopic dermatitis, where AMP levels are often pathologically low [6][7]. [1] https://pubmed.ncbi.nlm.nih.gov/22419111/ [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426243/ [3] https://www.uniprot.org/uniprotkb/P13573/entry [4] https://pubmed.ncbi.nlm.nih.gov/17440457/ [5] https://www.nature.com/articles/nri2170 [6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835876/ [7] https://pubmed.ncbi.nlm.nih.gov/21335971/

Other names

Keratinocyte innate immune signalingSkin antimicrobial peptide induction pathwayEpidermal AMP expression systemKeratinocyte host defense peptide machinery

Activation of pattern recognition receptors (PRRs) or nuclear receptors (e.g., VDR) triggers intracellular signaling cascades (e.g., MAPK, NF-kB, JAK-STAT) that lead to the transcriptional upregulation of genes encoding antimicrobial peptides such as cathelicidins and defensins.